Author | James T. Rosenbaum, MD

Dr. Rosenbaum, professor, Medicine and Ophthalmology, Joint Professor, Cell and Developmental Biology, Casey Eye Institute, Oregon Health & Science University, Portland.

Articles

Biologic agents treat ocular inflammatory disease

Editor's Note: As defined by the FDA, the term "biologics" refers to a wide range of products that includes vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins, such as monoclonal antibodies and antibody fragments.

New content coming soon, please check back later.